Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide for Acute Pulmonary Embolism
NCT01939301Phase 2Completed
- Sponsor
- Indiana University School of Medicine
- Start
- Oct 2013
- Primary completion
- Oct 2016
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary embolism (PE) comparing Inhaled Nitric Oxide with Placebo (2 arms). Primary endpoint: Number of Participants With Normal Right Ventricular (RV) Function and Viability at 5 days. Started Oct 2013; status: completed.
02
Drugs
nitric oxide
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT01939301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01939301.